510(k) K140094
K140094 is an FDA 510(k) premarket notification submitted by Eneura Therapeutics, LLC for the device "SPRINGTMS TOTAL MIGRAINE SYSTEM". The FDA issued a decision of Substantially Equivalent on May 21, 2014. The device falls under product code OKP (Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache), a Class II device regulated under 21 CFR 882.5808. Eneura Therapeutics, LLC has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 21, 2014
- Date Received
- January 14, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache
- Device Class
- Class II
- Regulation Number
- 882.5808
- Review Panel
- NE
- Submission Type
Transcranial magnetic stimulator for the treatment of migraine headache delivers brief duration, rapidly alternating, or pulsed, magnetic fields that are externally directed at spatially discrete regions of the brain to induce electric currents for the treatment of migraine headache.